News und Analysen

Risk is a big part of investing. An investment's return compensates investors for taking on the risk of a possible loss. Typically, the higher an investment's potential return, the greater the risk

It's a quiet week for earnings announcements, but one notable company stepping up to set sail is Carnival Corp. (NYSE: CCL). The world's largest cruise line operator reports its fiscal third-quarter

If you think that it's too late to hop on one of this year's bigger gainers, you may want to see some of the faces boarding Carnival Corp. (NYSE: CCL) shares with you. A lot of Wall Street pros are

The travel industry has been thriving this year as consumers are still making up for lost time due to the pandemic. And one of the companies that has been doing particularly well is Carnival Corp

Inflation is giving investors more of an incentive to find ways to increase their income. If you have a decent nest egg saved up, you can use it to invest in dividend stocks to improve your

Carnival (NYSE: CCL) was one of the companies worst-hit by the pandemic, and that impact hasn't ended. Debt has piled up and the company has big bills to pay. In this video, Travis Hoium covers the

After a devastating pandemic shutdown and a reemergence, Carnival Cruise Lines (NYSE: CCL) is finally surpassing 2019 levels on several metrics. Ships are near full capacity, and pent-up demand for

Fool.com contributor Parkev Tatevosian compares Carnival (NYSE: CCL) with Royal Caribbean (NYSE: RCL) to determine which is the better cruise ship stock to buy now.

*Stock prices used were the

Carnival (NYSE: CCL) (NYSE: CUK) has completed most of its recovery from the COVID-19 pandemic, which had decimated its business. Sales hit a second-quarter record this year, and bookings and

As the seasons shift and September ushers in a new phase for many markets, investors get an opportune time to consider potential avenues for growth and stability. In this exploration of top stock

Summer may be a great time for taking a cruise -- but it hasn't been a particularly bright time for Carnival (NYSE: CCL) (NYSE: CUK) shareholders. The world's biggest cruise operator's stock is down

Shares of Carnival (NYSE: CCL)(NYSE: CUK) stock fell 16% in August according to data provided by S&P Global Market Intelligence. The price had already doubled this year, and as the market dipped in

Carnival (NYSE: CCL)(NYSE: CUK) has turned a corner, and it's so far past it, you almost can't see the twists it has left behind. It's now back to its regularly scheduled growth -- or is it? Let's

If you're wondering whether to buy Viatris (NASDAQ: VTRS) stock this fall, it's important to know the arguments for why it might gain value as well as why it's not the best option.

Generic drug

The term "meme stocks" entered popular parlance during the pandemic when retail investors gathered together on some social media sites to drive certain stock prices through the roof. The pitfalls of

If you're looking for a high-yield dividend stock in the healthcare sector, you might be interested in comparing Takeda Pharmaceutical (NYSE: TAK) and Viatris (NASDAQ: VTRS).

Both companies offer

Viatris (NASDAQ: VTRS) hasn't made for a particularly great investment since it formed nearly three years ago, through a merger of Mylan and Pfizer's Upjohn business. Down 29% since then, it has

Carnival Corp. (NYSE: CCL) recently faced a bevy of operational challenges and a high-profile incident that may leave some investors watching carefully for signs of additional headwinds. These

Viatris (NASDAQ: VTRS) could be on the verge of eating the lunch of Novo Nordisk's (NYSE: NVO) two golden cash cows: The diabetes drug Ozempic, and another version that's formulated for weight loss

Cruise line stocks are rising again. Carnival (NYSE: CCL) is leading the way: Shares of the market leader have more than doubled this year. Unlike the surge in 2020 after the initial

Dividend stocks can be great additions to anyone's portfolio, and it's even better to buy quality ones when they're down. While the market has roared back this year following a downturn in 2022, it

Viatris (NASDAQ: VTRS) spun off from Pfizer and merged with Mylan back in 2020. It's a generic drugmaker with a diverse, global business that serves patients and customers in over 165 countries and

Carnival (NYSE: CCL)(NYSE: CUK) has lifted itself up from rock bottom to surpass previous sales records and keep growing. It's been a long and dramatic journey, and there are parts of it that will

Viatris (NASDAQ: VTRS) is a stock of immense interest among the dividend investing community, and it's no surprise why. Generic drugmakers, when operating smoothly, can be veritable cash machines

Especially if you're living on a fixed income, being able to bring in even $1,500 in extra money each year via dividends can be a big change for the better. But it's often difficult to figure out